LEADER 05813nam 2201633z- 450 001 9910404088603321 005 20231214132828.0 010 $a3-03928-311-1 035 $a(CKB)4100000011302252 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/54592 035 $a(EXLCZ)994100000011302252 100 $a20202102d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aNew Insights into Parvovirus Research 210 $cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 electronic resource (342 p.) 311 $a3-03928-310-3 330 $aViruses in the Parvoviridae family constitute one of the most diverse and intriguing fields of research. While they all share an ssDNA genome and a small capsid, they can differ widely in structure, genome organization and expression, virus?cell interaction, and impact on the host. Exploring such diversity and unraveling the inherent complexity in these apparently simple viruses is an ongoing endeavor and commitment for the scientific community. The translational implications of research on parvoviruses are relevant. Within the family, some viruses are important human and veterinary pathogens, in need of diagnostic methods and antiviral strategies; other viruses have long been studied and engineered as tools for oncolytic therapy, or as sophisticated gene delivery vectors, and can now display their wide and expanding applicative potential. This Special Issue of Viruses collects recent contributions in the field of parvovirus research, with a focus on new insights and research on unresolved issues, as well as new approaches exploiting systemic methodologies. Evolution, structural biology, viral replication, virus?host interaction, pathogenesis and immunity, and viral oncotherapy are a selection of the topics addressed in the issue that can be of relevance to the community involved in parvovirus research and of interest to a wider audience. 610 $aantivirals 610 $aBombyx mori bidensovirus 610 $aBocaparvovirus 610 $ahuman bocavirus 1 610 $aequine parvovirus-hepatitis 610 $aNS2 610 $aNS1 610 $aX-ray crystallography 610 $aBIRC3 (cIAP-2) 610 $aglycans 610 $achildren 610 $aantibody interactions 610 $anew viruses 610 $aalpaca 610 $acidofovir 610 $arodent protoparvoviruses 610 $aclinical trials 610 $astructural biology 610 $aDNA virus 610 $ahuman bocavirus 610 $acaspase-3 610 $aviral communities 610 $auncoating 610 $aPLA2 610 $aphospholipase-A2 610 $aoncolytic virus immune therapy 610 $aParvoviridae 610 $aviral ecology 610 $aCryo-EM 610 $aAAV 610 $ametagenomics 610 $aphylogeny 610 $aoncolytic viruses 610 $amite 610 $aparvovirus evolution 610 $aCarnivore protoparvovirus 1 610 $aadeno-associated virus 610 $atelbivudine 610 $acapsid stability 610 $avirus 610 $ahomology modeling 610 $ahuman airway epithelia 610 $asequence analysis 610 $aacute gastroenteritis 610 $abisulfite PCR 610 $anext-generation sequencing 610 $asingle stranded DNA virus 610 $aoverlapping promoters 610 $avirus diversity 610 $aprognosis 610 $aoncolytic activity 610 $agenome 610 $ahydroxyurea 610 $aLepidoptera 610 $agenome externalization 610 $aantiviral compounds 610 $acirculating angiogenic cells 610 $atumor microenvironment 610 $acoumarin derivatives 610 $anuclear targeting 610 $adensovirus 610 $areceptor interactions 610 $acell cycle arrest 610 $atranscription profile 610 $abrincidofovir 610 $acanine parvovirus 610 $aendogenous viral elements 610 $ainflammatory cardiomyopathy 610 $aerythroid progenitor cells 610 $aRNA-seq 610 $ainsect 610 $achapparvovirus 610 $aRT-qPCR 610 $atrafficking 610 $aAAV2 610 $aagricultural pests 610 $aAdeno-associated virus 610 $amyocarditis 610 $adiagnosis 610 $aparvovirus 610 $afeline panleukopenia virus 610 $achitin 610 $aB19V 610 $atranscription mapping 610 $aflavonoids 610 $aimmunomodulation 610 $aerythrovirus 610 $aapoptosis 610 $aadenoviral vector 610 $aanti-cancer 610 $adivalent cations 610 $aprotease 610 $agenetics 610 $apreclinical 610 $aarthropod 610 $aperitrophins 610 $abiocontrol 610 $adilated cardiomyopathy 610 $ainsect parvovirus 610 $acombination therapies 610 $aintravenous immunoglobulin (IVIG) 610 $avirus phylogeny 610 $aevolution 610 $asecond generation parvovirus treatments 610 $acommercial horse serum 610 $aparvovirus B19 610 $acanine chapparvovirus 610 $aCpG methylation 610 $aRACE 610 $aH-1PV 610 $aviral metagenomics 610 $ahorses 700 $aGallinella$b Giorgio$4auth$01311911 906 $aBOOK 912 $a9910404088603321 996 $aNew Insights into Parvovirus Research$93035501 997 $aUNINA